Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure

Abstract

These studies indicate the potential of oligonucleotide-based therapies for modulating cardiac miRNAs and validate miR-208 as a potent therapeutic target for the modulation of cardiac function and remodeling during heart disease progression.